We didnt overwhelm hospitals, we have contact teaching apps developed, we have a drug that's likely to be approved tonight or tommorow, and we have multiple vaccines in trials. We should have done a far better job early on, especially with testing, but the biopharma sector has risen to the challenge to move faster than basically every before.
